Historical shareholding details of The Goldman Sachs Group Inc holdings in Rigel Pharmaceuticals (RIGL)

Monthly changes of The Goldman Sachs Group Inc shareholding in Rigel Pharmaceuticals over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2025 The Goldman Sachs Group Inc 671,878 3.64%
Sep 30, 2025 The Goldman Sachs Group Inc 737,035 3.99%
Jun 30, 2025 The Goldman Sachs Group Inc 182,249 1.00%
Mar 31, 2025 Goldman Sachs Group Inc 59,474 0.33%
Dec 31, 2024 Goldman Sachs Group Inc 166,935 0.93%
Sep 30, 2024 Goldman Sachs Group Inc 46,113 0.26%
Jun 30, 2024 Goldman Sachs Group Inc 0 0.00%
Mar 31, 2024 Goldman Sachs Group Inc 409,482 0.23%
Dec 31, 2023 Goldman Sachs Group Inc 511,737 0.29%
Dec 29, 2023 Goldman Sachs Group Inc 255,676 0.15%
Sep 30, 2023 Goldman Sachs Group Inc 585,217 0.34%
Jun 30, 2023 Goldman Sachs Group Inc 513,635 0.29%
Mar 31, 2023 Goldman Sachs Group Inc 492,829 0.28%
Dec 30, 2022 Goldman Sachs Group Inc 9,370,063 5.37%

View all ownership details of Rigel Pharmaceuticals